Please login to the form below

Not currently logged in
Email:
Password:

Unichem

This page shows the latest Unichem news and features for those working in and with pharma, biotech and healthcare.

EU hits Servier and generic firms with €428m 'pay-for-delay' fine

EU hits Servier and generic firms with €428m 'pay-for-delay' fine

The generics companies implicated in the scandal - Niche/Unichem, Matrix (part of Mylan), Teva, Krka and Lupin - are facing penalties of 97m between them.

Latest news

  • EC lays formal antitrust charges against Servier

    In this latest action, the EC is claiming that patent settlement agreements between Servier and Teva, Matrix (now Mylan), Niche/Unichem, Krka and Lupin were specifically designed to delay the entry

  • Quantum Pharmaceutical hires Brian Fisher as commercial director

    This includes his two years at Alliance, as well as prior roles as UniChem, where he joined as business account manager before being promoted to head of hospitals and dispensing doctors.

  • Pfizer launches online portal for UK pharmacists

    2007. Pfizer's DTP arrangements saw it controversially decide to supply its medicines directly to pharmacists and pick just one distributor, Alliance Unichem, to handle the logistics of this.

  • Driving collaboration

    When Pfizer first launched its Direct to Pharmacy model in 2007, Alliance Healthcare (or UniChem as it then was) took the decision to adapt its business model and view manufacturers as

  • Pharma news in brief

    Investors query over Boots-Alliance UniChem tie-up. Investors have begun to question the logic of the £7bn merger of pharmacy and retail chain Boots and drug distributor Alliance UniChem to ... Shares in Alliance UniChem barely rose after the

More from news
Approximately 1 fully matching, plus 34 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

Transforming healthcare through effective collaboration. Making work to feel proud of. www.dovetailstrategies.com...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics